About The Personalized Medicine Coalition (PMC)
High on the list of breakthroughs expected to transform medicine is personalized medicine – the use of new methods of molecular analysis to better manage a patient’s disease or predisposition to disease. Personalized medicine is likely to change the way drugs are developed and medicine is prescribed.
Yet the regulatory and financial systems that will support personalized medicine are not yet in place. The mission of the PMC is to build the foundation that underpins the advancement of personalized medicine as a viable solution to the challenges of efficacy, safety and cost.
The Personalized Medicine Coalition (PMC), was launched in 2004 to educate the public and policymakers, and to promote new ways of thinking about health care. Today, PMC represents a broad spectrum of more than 225 innovator, academic, industry, patient, provider and payer communities, as we seek to advance the understanding and adoption of personalized medicine concepts and products for the benefit of patients.
What is Personalized Medicine?
As defined by the President’s Council on Advisors on Science and Technology, “Personalized Medicine” refers to the tailoring of medical treatment to the individual characteristics of each patient…to classify individuals into subpopulations that differ in their susceptibility to a particular disease or their response to a specific treatment. Preventative or therapeutic interventions can then be concentrated on those who will benefit, sparing expense and side effects for those who will not.